Botox 1 Area (Azzalure/Botox/Alluzience)

A single-area botulinum toxin injection using Azzalure, Botox, or Alluzience to temporarily relax dynamic facial muscles. Commonly applied to forehead lines, frown lines (glabella), or crow's feet around the eyes.

Botulinum toxin type A is the most widely used injectable neuromodulator in aesthetic medicine, and K2 Medical offers three established brands — Azzalure (Galderma), Botox (Allergan), and Alluzience (Galderma) — allowing the treating physician to select the formulation best suited to each patient's anatomy and treatment goals. A single-area session targets one of the three primary upper-face zones: horizontal forehead lines, vertical glabellar frown lines between the brows, or lateral periorbital lines (crow's feet). The mechanism of action is consistent across all three brands: the toxin blocks acetylcholine release at the neuromuscular junction, preventing the targeted muscle from contracting at full force. This reduces the appearance of dynamic wrinkles — creases that form when the muscle moves — while preserving natural facial expression when injected at appropriate doses. The onset of visible smoothing typically begins within 3 to 5 days, with full effect at 10 to 14 days post-injection. The procedure itself takes approximately 20 minutes including consultation, facial assessment, and injection. The physician maps the injection points based on individual muscle anatomy, using fine-gauge needles to deliver small aliquots of toxin into the target muscle bellies. Most patients describe the sensation as a brief pinch at each injection site; topical anaesthetic is available but rarely necessary. Results from a single-area treatment last 3 to 6 months depending on the individual's metabolism, muscle mass, and activity level. K2 Medical recommends follow-up treatments at regular intervals to maintain the smoothing effect, with many patients finding that muscle retraining over time allows for longer intervals between sessions.